<DOC>
	<DOCNO>NCT00784680</DOCNO>
	<brief_summary>To compare Quality Life ARIMIDEX group , NOLVADEX group ARIMIDEX plus NOLVADEX combination group first two year treatment . ( ) To compare difference Quality Life ARIMIDEX group NOLVADEX group ( b ) To compare Quality Life ARIMIDEX plus NOLVADEX combination group NOLVADEX group non-inferiority ; non inferiority conclude , difference QOL two group assess .</brief_summary>
	<brief_title>ATAC - Quality Life Sub-Protocol</brief_title>
	<detailed_description />
	<mesh_term>Anastrozole</mesh_term>
	<mesh_term>Tamoxifen</mesh_term>
	<criteria>Eligible entry main ATAC trial 1033IL/0029 Completion baseline questionnaire Excluded entry main ATAC trial ( 1033IL/0029 ) If , investigator opinion , patient would unable comply subprotocol due psychiatric literacy reason</criteria>
	<gender>Female</gender>
	<minimum_age>45 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2009</verification_date>
</DOC>